BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11735200)

  • 1. A new device for the measurement of disease severity in patients with intermittent claudication.
    Coughlin PA; Kent PJ; Turton EP; Byrne P; Berridge DC; Scott DJ; Kester RC
    Eur J Vasc Endovasc Surg; 2001 Dec; 22(6):516-22. PubMed ID: 11735200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PADHOC device is a better guide to the actual incapacity suffered by claudicants than the gold standard constant load treadmill test.
    Coughlin PA; Kent PJ; Berridge DC; Scott DJ; Kester RC
    Eur J Vasc Endovasc Surg; 2006 Dec; 32(6):651-6. PubMed ID: 16679038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system.
    Le Faucheur A; Abraham P; Jaquinandi V; Bouyé P; Saumet JL; Noury-Desvaux B
    Circulation; 2008 Feb; 117(7):897-904. PubMed ID: 18250268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of constant-load treadmill testing in patients with intermittent claudication.
    Falkensammer J; Gasteiger S; Polaschek B; Gruber I; Frech A; Fraedrich G; Schocke M; Greiner A
    Int Angiol; 2012 Apr; 31(2):150-5. PubMed ID: 22466980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speed rather than distance: a novel graded treadmill test to assess claudication.
    Manfredini F; Conconi F; Malagoni AM; Manfredini R; Mascoli F; Liboni A; Zamboni P
    Eur J Vasc Endovasc Surg; 2004 Sep; 28(3):303-9. PubMed ID: 15288635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plantar flexion as an alternative to treadmill exercise for evaluating patients with intermittent claudication.
    Yamamoto K; Miyata T; Onozuka A; Koyama H; Ohtsu H; Nagawa H
    Eur J Vasc Endovasc Surg; 2007 Mar; 33(3):325-9. PubMed ID: 17137808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication.
    Frans FA; Zagers MB; Jens S; Bipat S; Reekers JA; Koelemay MJ
    J Vasc Surg; 2013 Mar; 57(3):720-727.e1. PubMed ID: 23313183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective determination of the predefined duration of a constant-load diagnostic tests in arterial claudication.
    Mahe G; Abraham P; Zeenny M; Bruneau A; Vielle B; Leftheriotis G
    J Vasc Surg; 2010 Apr; 51(4):863-8. PubMed ID: 20347682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a short-course intensive rehabilitation program in patients with moderate-to-severe intermittent claudication.
    Ambrosetti M; Salerno M; Tramarin R; Pedretti RF
    Ital Heart J; 2002 Aug; 3(8):467-72. PubMed ID: 12407823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treadmill testing in the assessment of peripheral arterial disease.
    Laing S; Greenhalgh RM
    Int Angiol; 1986; 5(4):249-52. PubMed ID: 3585097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D; Bronas UG; Leon AS
    Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending the range of treadmill testing for patients with intermittent claudication.
    Nicolaï SP; Leffers P; Kruidenier LM; De Bie RA; Prins MH; Teijink JA
    Med Sci Sports Exerc; 2010 Apr; 42(4):640-5. PubMed ID: 19952843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Objective evaluation of arterial intermittent claudication by the walking tolerance test. Comparative study of physiological walking and walking on a conveyor belt (author's transl)].
    Bouchet JY; Franco A; Morzol B; Beani JC
    J Mal Vasc; 1980; 5(3):177-9. PubMed ID: 7462848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?
    Leone A; Laudani R; Definite G; Martini R; Andreozzi GM
    Minerva Cardioangiol; 2009 Apr; 57(2):165-74. PubMed ID: 19274027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP; Anthony R; Cobb FR; Koda I; Jiao J; Hiatt WR
    J Am Coll Cardiol; 2006 Dec; 48(12):2539-45. PubMed ID: 17174195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudication distance is poorly estimated and inappropriately measured.
    Watson CJ; Phillips D; Hands L; Collin J
    Br J Surg; 1997 Aug; 84(8):1107-9. PubMed ID: 9278653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single treadmill exercise test does not accurately quantitate claudication.
    Harris KA; Meads GE
    Can J Surg; 1987 Nov; 30(6):446-8. PubMed ID: 3664415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal cardiovascular response to exercise in patients with peripheral arterial disease: Implications for management.
    Oka RK; Altman M; Giacomini JC; Szuba A; Cooke JP
    J Vasc Nurs; 2005 Dec; 23(4):130-6; quiz 137-8. PubMed ID: 16326331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
    Andreozzi GM; Leone A; Laudani R; Deinite G; Martini R
    Int Angiol; 2007 Mar; 26(1):12-7. PubMed ID: 17353883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.